Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Hum Immunol. 2010 Jun 20;71(9):865–873. doi: 10.1016/j.humimm.2010.06.008

Figure 6. Ingenuity Canonical Pathway Analysis of the genes associated with the 356 probes that were increased in both acute KD and IVIG-resistant KD subjects.

Figure 6

A grey shaded molecule refers to a probe that was more abundant in acute KD subjects vs. both convalescent KD subjects and healthy control as well as more abundant in IVIG-resistant compared to IVIG-responsive KD subjects.